Search research articles
Contact Us
Filters
Showing results (161-170 of 325) with videos related to
Page
of 33
Sort By:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
October 13, 2021
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
Mohsen Sadatsafavi, J Mark FitzGerald, Paul M O'Byrne, et al.
The Journal of Allergy and Clinical Immunology
|
December 15, 2019
Cost-effectiveness of implementing objective diagnostic verification of asthma in the United States
Mohsen Yaghoubi, Amin Adibi, Zafar Zafari, et al.
Journal of the American College of Cardiology
|
June 20, 2006
Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease
G B John Mancini, Mahyar Etminan, Bin Zhang, et al.
BMC Pulmonary Medicine
|
May 21, 2009
Economic burden of asthma: a systematic review
Katayoun Bahadori, Mary M Doyle-Waters, Carlo Marra, et al.
Respiratory Medicine
|
September 12, 2020
The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK
J Mark FitzGerald, Sofie Arnetorp, Caitlin Smare, et al.
The Lancet. Respiratory Medicine
|
March 18, 2020
The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study
Amin Adibi, Don D Sin, Abdollah Safari, et al.
Allergy
|
May 12, 2016
The asthma control in daily practice
G Ciprandi, M A Tosca, I Cirillo, et al.
BMC Infectious Diseases
|
November 17, 2016
Predictors of hospitalization of tuberculosis patients in Montreal, Canada: a retrospective cohort study
Lisa A Ronald, J Mark FitzGerald, Andrea Benedetti, et al.
Immunotherapy
|
November 6, 2019
Reslizumab and mepolizumab for moderate-to-severe poorly controlled asthma: an indirect comparison meta-analysis
Kevin Yan, Chakrapani Balijepalli, Rohini Sharma, et al.
The European Respiratory Journal
|
March 22, 2020
Avoiding immortal time bias in observational studies
Adam J N Raymakers, Mohsen Sadatsafavi, Don D Sin, et al.
Page
of 33
Search research articles
Search
Showing results (161-170 of 325) with videos related to
Sort By:
Page
of 33
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
October 13, 2021
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
Mohsen Sadatsafavi, J Mark FitzGerald, Paul M O'Byrne, et al.
The Journal of Allergy and Clinical Immunology
|
December 15, 2019
Cost-effectiveness of implementing objective diagnostic verification of asthma in the United States
Mohsen Yaghoubi, Amin Adibi, Zafar Zafari, et al.
Journal of the American College of Cardiology
|
June 20, 2006
Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease
G B John Mancini, Mahyar Etminan, Bin Zhang, et al.
BMC Pulmonary Medicine
|
May 21, 2009
Economic burden of asthma: a systematic review
Katayoun Bahadori, Mary M Doyle-Waters, Carlo Marra, et al.
Respiratory Medicine
|
September 12, 2020
The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK
J Mark FitzGerald, Sofie Arnetorp, Caitlin Smare, et al.
The Lancet. Respiratory Medicine
|
March 18, 2020
The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study
Amin Adibi, Don D Sin, Abdollah Safari, et al.
Allergy
|
May 12, 2016
The asthma control in daily practice
G Ciprandi, M A Tosca, I Cirillo, et al.
BMC Infectious Diseases
|
November 17, 2016
Predictors of hospitalization of tuberculosis patients in Montreal, Canada: a retrospective cohort study
Lisa A Ronald, J Mark FitzGerald, Andrea Benedetti, et al.
Immunotherapy
|
November 6, 2019
Reslizumab and mepolizumab for moderate-to-severe poorly controlled asthma: an indirect comparison meta-analysis
Kevin Yan, Chakrapani Balijepalli, Rohini Sharma, et al.
The European Respiratory Journal
|
March 22, 2020
Avoiding immortal time bias in observational studies
Adam J N Raymakers, Mohsen Sadatsafavi, Don D Sin, et al.
Page
of 33